Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Emodepside IR Tablets vs Oral Solution
NCT03383523Phase 1Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of emodepside in onchocerciasis (7 arms), sponsored by Drugs for Neglected Diseases initiative. Primary endpoints: Area Under the Curve from 0 to 7 days and Maximum Plasma Concentration at 7 days. Started Oct 2017; status: completed.
02
Drugs
emodepside
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT03383523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383523.